(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 33.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.69%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Delcath Systems's revenue in 2026 is $79,603,000.On average, 9 Wall Street analysts forecast DCTH's revenue for 2026 to be $4,084,384,624, with the lowest DCTH revenue forecast at $3,324,327,471, and the highest DCTH revenue forecast at $4,794,190,356. On average, 9 Wall Street analysts forecast DCTH's revenue for 2027 to be $5,447,847,276, with the lowest DCTH revenue forecast at $4,191,032,052, and the highest DCTH revenue forecast at $6,544,691,357.
In 2028, DCTH is forecast to generate $6,725,497,593 in revenue, with the lowest revenue forecast at $4,748,282,522 and the highest revenue forecast at $7,929,695,377.